Moreover, restoring the GPR35‐TRPV4 interaction using Thonningianin A or Carfilzomib effectively prevented endothelial dysfunction and impaired vasodilation in small mesenteric arteries of aging mice. The gene discussed is GPR35; the disease is endothelial dysfunction.